New York’s Montefiore Headache Center helped conduct a large-scale clinical trial testing Allergan’s ubrogepant with migraine headache patients. The new drug shows promise. Migraine: A Massive Problem Up to 40 million Americans and one billion worldwide suffer form...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
